|
|
Sold Out
Book Categories |
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing — atom by atom — both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.
You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
A startup pharmaceutical company is the focus of this intriguing look at the nexus of biotechnology and high finance; features a new epilogue by the author. (Mar.)
| Price | Condition | Delivery | Seller | Action |
| $99.99 | Digital |
| WonderClub |
Fahd Abouabsi
reviewed The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug on August 02, 2019
The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug
A very interesting story of a pharmaceutical startup. So much hype, with no solid basis, and yet they survive. Werth does a good job explaining the business, the science, and the experience of doing the science.
> Scientists, unlike, say, athletes, conjure their own competition. They seldom know precisely whom they're competing with or where they are in the race. They hear things'rumors, reports'but the information comes at a distance and with a price: It may be exaggerated, deliberately misleading, or simply false. The atmosphere in a lab in the throes of a heated project is insular, secretive, xenophobic, superheated, and paranoid.
> "There's two situations where you want to be aggressive about publishing. One is when you're behind; the other is when you're ahead. When you're ahead, you demoralize the other guy. When you're behind, you have nothing to lose. It's when you don't know that you want to be most careful."
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug
X
This Item is in Your Inventory
The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug
X
You must be logged in to review the productsX
X
X
Add The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug, Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dyna, The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug to the inventory that you are selling on WonderClubX
X
Add The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug, Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dyna, The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug to your collection on WonderClub |